{"symbol": "CYTR", "companyName": "CytRx Corporation", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.cytrx.com", "description": "CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).", "CEO": "Steven A. Kriegsman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}